Trial site
Essen
- 18running trials
- 21closed trials
The trials here
What the 39 trials at this site are about, from their registry records.
- Conditions
- Lung cancer10 trials
- Colorectal cancer7 trials
- Melanoma5 trials
- Triple-negative breast cancer5 trials
- Coronary artery disease4 trials
- Metastatic breast cancer4 trials
- Multiple sclerosis4 trials
- Pancreatic cancer4 trials
- Prostate cancer4 trials
- Gastric and oesophageal cancer3 trials
- Head and neck cancer2 trials
- Kidney cancer2 trials
- and 15 more
- Phase
- Phase 311 trials
- Phase 110 trials
- Phase 26 trials
- Phase 1/25 trials
- Early phase 11 trial
- Phase 41 trial
- Status
- Active, not recruiting13 trials
- Completed11 trials
- Terminated9 trials
- Recruiting5 trials
- Withdrawn1 trial
- Lead sponsor
- Novartis Pharmaceuticals39 trials
Running trials
Active, not recruiting
Recruiting
Recruiting
Recruiting
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors
Active, not recruiting
Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria
Active, not recruiting
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
Active, not recruiting
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Prostate cancer3 recruiting
- Colorectal cancer2 recruiting
- Lung cancer2 recruiting
- Pancreatic cancer2 recruiting
- Triple-negative breast cancer2 recruiting
- Sarcoma1 recruiting
Closed trials
Completed
Terminated
Terminated
To Assess the Efficacy of the Investigational Products Compared to Placebo in Participants With IPF
Completed
Recruiting
Completed
Terminated
Terminated
Terminated
Completed
Study of Efficacy, Safety and Tolerability of CMK389 in Patients With Chronic Pulmonary Sarcoidosis
Terminated
Terminated
A Phase I/Ib Study of NIZ985 Alone and in Combination With Spartalizumab
Completed
Completed
Completed
Completed
Terminated
A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma
Terminated
Completed
Completed
Completed
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
Site data: ClinicalTrials.govUpdated 18 Nov 2026